NatureCell (007390) Fundamentals 2026 — Revenue Analysis | SniperIQ
NatureCell (007390) is a KR-listed Consumer Defensive company in Beverages - Non-Alcoholic with a market capitalization of ₩1.46T, trading at ₩22650.00 on the KOE. This SniperIQ fundamentals page covers NatureCell's valuation, profitability (net margin -13.2%), revenue (₩20.8B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is NatureCell's market cap?
NatureCell (007390) has a market capitalization of approximately ₩1.46T, trading at ₩22650.00 on the KOE. Market cap moves with the live share price.
What is NatureCell's P/E ratio?
NatureCell's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 23.1x. Valuation multiples are best compared with Consumer Defensive sector peers rather than read in isolation.
How profitable is NatureCell?
NatureCell runs a net profit margin of -13.2%, a gross margin of 45.1%, and an operating margin of -15.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does NatureCell generate?
NatureCell reported revenue of ₩20.8B for fiscal year 2025, with net income of -₩2.8B and earnings per share (EPS) of -44.07. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does NatureCell pay a dividend?
NatureCell does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is NatureCell financially healthy?
NatureCell carries a debt-to-equity ratio of 0.31x and a current ratio of 1.94x, with a market beta of 0.88. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is NatureCell a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For NatureCell (007390) the key facts are: market cap ₩1.46T, revenue ₩20.8B, 52-week range 16550-39350. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Defensive peers and form your own view.
Track NatureCell's full fundamentals live
Get NatureCell's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.